Tricia Rodriguez, Truveta senior applied research scientist & lead study author, explains the study findings concerning why ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

How and why the drugs have such wide-ranging health benefits is subject to further research, and the GLP-1 drugs were found ...

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 ...

Recent research out of Cornell University showed that GLP-1 users' grocery bills have been reduced by as much as 8.6% — with ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Though they found more benefits associated with the GLP-1 drugs than risks, study author Dr. Ziyad Al-Aly, who is chief of research and development at the VA St. Louis Health Care System, said ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...

A comprehensive new study confirmed that GLP-1 medications such as Ozempic and Mounjaro have myriad health benefits — even more than previously thought. Analyzing the medical records of roughly ...